Three‐step hydroxylation of vitamin D<sub>3</sub> by a genetically engineered CYP105A1

Keiko Hayashi(Toyama Prefectural University), Toshiyuki Sakaki(Toyama Prefectural University)

FEBS Journal

August 20, 2010

10.1111/j.1742-4658.2010.07791.x

Cited by 43

Related Papers

Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D3 in human prostate cells

|Journal of Molecular Endocrinology|2011|24

Influence of sesamin on<scp>CYP</scp>2C‐mediated diclofenac metabolism: in vitro and in vivo analysis

|Pharmacology Research & Perspectives|2015|15

Human hepatic metabolism of the anti‐osteoporosis drug eldecalcitol involves sterol C4‐methyl oxidase

|Pharmacology Research & Perspectives|2015|6

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector

|Scientific Reports|2023|5

Characterization of Rickets Type II Model Rats to Reveal Functions of Vitamin D and Vitamin D Receptor

|Biomolecules|2023|4